Mycoplasma pneumoniaepneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ)
Open Access
- 13 May 2009
- journal article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 9 (1) , 62
Abstract
Currently, broad empiric antimicrobial treatment including atypical coverage is recommended for patients with mild to moderate community-acquired pneumonia (CAP). Therefore, the relative impact of each atypical pathogen, particularly Mycoplasma pneumoniae deserves renewed attention.Keywords
This publication has 25 references indexed in Scilit:
- Community‐AcquiredLegionellaPneumonia: New Insights from the German Competence Network for Community Acquired PneumoniaClinical Infectious Diseases, 2008
- Sensitive Detection of Mycoplasma pneumoniae in Human Respiratory Tract Samples by Optimized Real-Time PCR ApproachJournal of Clinical Microbiology, 2007
- Ten years’ experience with year-round active surveillance of up to 19 respiratory pathogens in childrenEuropean Journal of Pediatrics, 2007
- Low prevalence of Chlamydia pneumoniae in adults with community-acquired pneumoniaInternational Journal of Medical Microbiology, 2006
- Effectiveness of β lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysisBMJ, 2005
- Molecular Diagnosis of Mycoplasma pneumoniae Respiratory Tract InfectionsJournal of Clinical Microbiology, 2003
- Community-Acquired PneumoniaMedicine, 2001
- Mycoplasma pneumoniae Community-Acquired Pneumonia: A Review of 101 Hospitalized Adult PatientsRespiration, 1996
- Comparative clinical and laboratory features of legionella with pneumococcal and mycoplasma pneumoniasRespiratory Medicine, 1987
- Etiology of community-acquired pneumonia in patients requiring hospitalizationEuropean Journal of Clinical Microbiology & Infectious Diseases, 1985